Search

Author/Creator Chandra, D

2. DOP72 Safety, tolerability and efficacy of anti-TL1A antibody PF-06480605 in treatment of ulcerative colitis: The open-label, multicentre, Phase 2a TUSCANY study. (15th January 2020)

Authors:
Danese, S; Klopocka, M; Scherl, E J; Romatowski, J; Allegretti, J R; Peeva, E; Vincent, M S; Schoenbeck, U; Xi, L; Ye, Z; Hassan-Zahraee, M; Rath, N; Li, G; Neelakantan, S; Banfield, C; Lepsy, C; Chandra, D; Hung, K E
Journal:
Journal of Crohn's and colitis
Issue:
Volume 14(2020)Supplement 1
Page Start:
S108
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗